Positive predictive value of International Classification of Diseases, 10th revision, diagnosis codes for cardiogenic, hypovolemic, and septic shock in the Danish National Patient Registry by Marie Dam Lauridsen et al.
Lauridsen et al. BMC Medical Research Methodology  (2015) 15:23 
DOI 10.1186/s12874-015-0013-2RESEARCH ARTICLE Open AccessPositive predictive value of International
Classification of Diseases, 10th revision, diagnosis
codes for cardiogenic, hypovolemic, and septic
shock in the Danish National Patient Registry
Marie Dam Lauridsen1*, Henrik Gammelager1,2, Morten Schmidt1, Henrik Nielsen1
and Christian Fynbo Christiansen1Abstract
Background: Large registries are important data sources in epidemiological studies of shock, if these registries are
valid. Therefore, we examined the positive predictive value (PPV) of diagnosis codes for shock, the procedure codes
for inotropic/vasopressor therapy among patients with a diagnosis of shock, and the combination of a shock
diagnosis and a code for inotropic/vasopressor therapy in the Danish National Patient Registry (DNPR).
Methods: We randomly selected 190 inpatients with an International Classification of Diseases, 10th revision
(ICD-10) diagnosis of shock at Aarhus University Hospital from 2005–2012 using the DNPR; 50 patients were
diagnosed with cardiogenic shock, 40 patients with hypovolemic shock, and 100 patients with septic shock. We
used medical charts as the reference standard and calculated the PPV with 95% confidence intervals (CI) for overall
shock and for each type of shock separately. We also examined the PPV for inotropic/vasopressor therapy and the
PPV for shock when a concurrent code for inotropic/vasopressor therapy was also registered.
Results: The PPV was 86.1% (95% CI: 79.7–91.1) for shock overall, 93.5% (95% CI: 82.1–98.6) for cardiogenic shock, 70.6%
(95% CI: 52.5–84.9) for hypovolemic shock, and 69.2% (95% CI: 57.7–79.2) for septic shock. The PPV of use of inotropes/
vasopressors among shock patients was 88.9% (95% CI: 79.3–95.1). When both a shock code and a procedure code for
inotropic/vasopressor therapy were used, the PPV for shock overall was 93.1% (95% CI: 84.5–97.7). ICD-10 codes for
subtypes of shock and simultaneously registered use of inotropes/vasopressors provided PPVs of 96.0% (95% CI:
79.6–99.9) for cardiogenic shock, 69.2% (95% CI: 38.6–90.9) for hypovolemic shock, and 82.4% (95% CI: 65.5–93.2) for
septic shock.
Conclusions: Overall, we found a moderately high PPV for shock in the DNPR. The PPV was highest for cardiogenic
shock but lower for hypovolemic and septic shock. Combination diagnoses of shock with codes for inotropic/
vasopressor therapy further increased the PPV of shock overall, and for cardiogenic and septic shock diagnoses.
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Shock is a medical emergency in which organs and tis-
sues of the body are not receiving adequate flow of
blood, resulting in decreased oxygen delivery for cell
metabolism [1]. Shock is defined as sustained systolic
blood pressure below 90 mmHg, or a drop of systolic
blood pressure of more than 40 mmHg in patients with
hypertension [1]. Moreover, cutaneous, renal, and neuro-
logical symptoms are often observed as clinical manifes-
tations of shock, and increased serum lactate is often a
biochemical sign of abnormal oxygen metabolism in pa-
tients with shock [1]. If left untreated, shock can lead to
severe organ damage and death [2,3]. Shock is typically
categorized as cardiogenic, hypovolemic, obstructive, or
distributive shock. The most common cause of distribu-
tive shock is septic shock [4].
Large registries enable efficient and low cost research
[5]. However, registry data must be of high validity for
use in epidemiologic research.
The positive predictive value (PPV) for shock among
patients with myocardial infarction in two Canadian
hospital discharge registries has been found to be 75.0%
(95% confidence interval [CI]: 19.4–99.4) [6] and 78.8%
(95% CI: 67.0–87.9) [6,7]. In addition, the PPV for severe
sepsis, including septic shock, is reported to be 70.7%
(95% CI: 51.1–90.4) [8]. No previous study has examined
the validity of cardiogenic, hypovolemic, or septic shock
diagnoses in the Danish National Patient Registry
(DNPR). Therefore, we examined the PPV of (1) diagno-
sis codes for cardiogenic shock, hypovolemic shock, and
septic shock in the DNPR overall and for each code sep-
arately, (2) treatment codes for inotropic/vasopressor
therapy in the DNPR among patients diagnosed with
shock, and (3) shock diagnoses when an in-hospital
treatment with inotropes/vasopressors is also registered.
Methods
Design and setting
We conducted this cross-sectional validation study using
data from medical registries in Denmark. The Danish
National Health Service provides tax-supported health
care to all Danish residents, including universal and free
access to general practitioners and hospitals in Denmark
[9]. We used the unique 10-digit Civil Person Registra-
tion number, assigned to all inhabitants at birth or upon
immigration, to identify medical charts [10].
Identification of patients with shock in the DNPR
We used the DNPR to identify a random sample of 190
patients admitted with cardiogenic, hypovolemic, or sep-
tic shock to Aarhus University Hospital from 1 January
2005 through 31 December 2012. We used both primary
and secondary inpatient diagnosis codes to identify the
sample of shock patients. Data on all somatic hospitaladmissions have been routinely registered in the DNPR
since 1977, and all outpatient and emergency contacts
have been included since 1995 [11]. Each admission is
registered by one primary diagnosis code and up to 19
secondary diagnosis codes classified according to the
International Classification of Diseases, 8th revision
(ICD-8) until the end of 1993, and according to the 10th
revision (ICD-10) thereafter [11]. Procedures of ino-
tropic/vasopressor therapy have been registered rou-
tinely since 2005 [12].
We chose to include a minimum of 40 cases for each
shock type to allow sufficient precision of the calculated
PPV, and because of the maximum available number of
coded cases in the study period for all shock types. With
this number of cases, a PPV of 90% for shock subtypes
would result in a 95% confidence interval (CI) from 76%
to 97%, which we considered acceptable. The total num-
ber of patients (190) included in the study and the distri-
bution of patients in the three subgroups of shock were
based on the distribution of the three shock subtypes
registered in the DNPR in the study period. We ran-
domly included patients of the three shock subtypes reg-
istered in the DNPR in the study period until at least 40
patients in each subgroup of shock were reached. Data
on treatment with inotropes/vasopressors were obtained
by in-hospital treatment codes during hospitalization
from the DNPR (codes provided in Additional file 1:
Table e1).
We obtained data on age and sex from the Danish
Civil Registration System [10].
To assess the level of comorbidities, we used the
Charlson Comorbidity Index (CCI) [13]. The CCI is a
validated scoring system that has been adapted for use
with hospital discharge data [14]. The scoring system
assigns a point score from 1 to 6 to a number of dis-
eases depending on their relation to mortality, defined
during a one-year period in which the scoring was made
[13]. The scoring system generated three levels of co-
morbidity: 0 (low), 1–2 (moderate), and ≥ 3 (high). For
each patient, we used a fixed period of 5 years prior to
hospital admission with shock, and included any in-
patient or outpatient hospital visits with a diagnosis of
the diseases, including both prevalent and incident dis-
eases. ICD-10 codes are provided in Additional file 1:
Table e2.
Medical chart review
One author (MDL) obtained and reviewed all available
medical charts. Each chart was reviewed, including all notes
from date of hospital admission with shock to the date of
hospital discharge. This approach was chosen to confirm
shock diagnosis and type of shock by predefined diagnostic
criteria (Table 1), and to confirm treatment with inotropes/
vasopressors.
Table 1 Diagnostic criteria used to validate shock diagnoses.
Shock type Diagnostic criteria
Shock overall Diagnosis of shock is confirmed if sustained shocka can be confirmed by medical chart review by at least one
of the following [1,15]:b
1. Systolic blood pressure < 90 mmHg.
2. Mean arterial pressure < 70 mmHg.
3. Reduction in systolic blood pressure > 40 mmHg.
4. Preserved systolic blood pressure achieved through inotropic/vasopressor therapy.
Cardiogenic shock Diagnosis of cardiogenic shock is confirmed if medical chart review confirms these two criteria [4,16]:
1. Sustained shock (as defined in shock overall) [1,15], and
2. Two or more of the following criteria were confirmed:
a. Cardiac index < 2.2 (L/min)/m2,
b. pulmonary capillary wedge pressure > 18 mmHg,
c. tachycardia (>90 beats per minute),
d. pale, cold, clammy, or cyanotic skin,
e. signs of oliguria, or
f. confusion, disorientation, or loss of conscience.
Hypovolemic shock Diagnosis of hypovolemic shock is confirmed if medical chart review confirms these two criteria:
1. Sustained shock (as defined in shock overall) [1,15]
2. Evidence or suspicion of shock due to (one or more of the following) [4]:
a. Loss of red blood cell mass and plasma from hemorrhage.
b. Loss of plasma volume alone due to extravascular fluid sequestration.
c. Gastrointestinal, urinary, and insensible losses.
Septic shock Diagnosis of septic shock is confirmed if medical chart review confirms these three criteria [1,15,17]:
1. Sustained shock (as defined in shock overall) [1,15]
2. Systemic inflammatory response syndrome (SIRS) must be diagnosed by identifying at least two or
more of the following:
a. Tachypnea: high respiratory rate) > 20 breaths per minute, or arterial blood gas, with PCO2 less
than 4.3 kPa signifying hyperventilation.
b. White blood cell count either significantly low < 4000 cells/mm3, elevated > 12000 cells/mm3,
or >10 immature cells.
c. Heart rate > 90 beats per minute.
d. Temperature: Fever > 38.3°C (100.4°F) or hypothermia < 36.0°C (96.8°F).
3. Sepsis and not an alternative form cause of SIRS. Sepsis requires evidence or suspicion of infection,
which may include:
a. Positive blood culture/blood culture taken as suspicious of infection,
b. signs of pneumonia on chest x-ray, or
c. other radiologic or laboratory evidence of infection.
aSustained shock defined as shock > 30 minutes despite adequate fluid resuscitation.
bBlood pressure used as a surrogate for decreased blood flow.
Abbreviation: SIRS Systemic inflammatory response syndrome.
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We tabulated patient characteristics by shock type, in-
cluding 1) median age and interquartile range, 2) gender
and level of comorbidity as counts and percentages.
We used the STATA command diagt (diagnostic test) to
estimate the PPV as the proportion of registered diagnoses
confirmed by the predefined criteria during medical chart
review. Ninety-five percent CIs are given as the exactbinomial CI. The calculations were done under the as-
sumption that all the missing medical charts did not differ
from the charts found in the archives with respect to the
proportion of confirmed shock cases. To ensure that no
substantial differences existed between patients with avail-
able medical charts and patients with missing medical
charts, we (1) compared the two groups of patients with
regard to gender, age, and level of comorbidity, (2)
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bidity were predictors of misclassification using a logistic
regression model with verified shock as the outcome, and
(3) conservatively estimated the PPV for shock and sub-
types of shock by including missing medical charts as
non-confirmed shock.
We calculated the PPV for use of inotropes/vasopres-
sors among patients having a diagnosis code of shock.
Patients that have a confirmed treatment with inotropes/
vasopressors in the medical chart were used as the nu-
merator, and patients with a procedure code of ino-
tropic/vasopressor therapy defined the denominator.
To examine whether the PPVs for shock overall and
shock subtypes could be improved using a concurrent
procedure code of inotropic/vasopressor therapy, we es-
timated the PPV as the proportion of confirmed shock
cases among patients registered with both a shock diagno-
sis and an inotropic/vasopressor code. For all statistical
analyses, we used STATA statistical software version 13.1
(StataCorp LP, Texas).
Research ethics and informed consent
This validation study was non-experimental and solely
used existing data; thus, ethical approval was not needed.
The study was approved by the Danish Data Protection
Agency (record no. 2006-53-1346).
Results
Patient characteristics
Among the medical charts reviewed, 46 of 50 (92%) were
available for cardiogenic shock validation, 78 of 100 (78%)
were available for septic shock validation, and 34 of 40
(85%) were available for hypovolemic shock validation. A
flowchart showing the selection process is provided in
Figure 1.
Patients with missing charts were slightly younger, and
the majority were men (Additional file 1: Table e3). The
level of comorbidity did not differ substantially between
patients with and without an available medical chart
(Additional file 1: Table e3).
The median age at hospital admission among patients
with a code of shock was 71 years (interquartile range:
61–80), and the distribution between males and females
was equal (Table 2). Patients with cardiogenic shock
had an overall lower level of comorbidity compared
with patients with hypovolemic and septic shock
(Table 2).
Positive predictive value for shock and subtypes of shock
The PPV for shock overall was 86.1% (95% CI: 79.7–
91.1) (Table 3). The PPVs were 93.5% (95% CI: 82.1–
98.6) for cardiogenic shock, 70.6% (95% CI: 52.5–84.9)
for hypovolemic shock, and 69.2 % (95% CI: 73.3–94.2)
for septic shock (Table 3). Patients who did not fulfillthe diagnostic criteria were equally distributed in groups
of patients with unconfirmed shock and patients not ful-
filling the specific shock subtype criteria (Figure 1).
When we included missing medical charts as uncon-
firmed shock in the calculations, the PPV was 71.6%
(95% CI: 65.2–78.0) for shock overall, 86.0% (95% CI:
73.3–94.2) for cardiogenic shock, 60.0% (95% CI: 43.3–
75.1) for hypovolemic shock, and 54.0% (95% CI: 43.7–
64.0) for septic shock (Additional file 1: Table e4).
Male gender, age less than 60 years, and a high level
of comorbidities may be predictors of misclassification,
although estimates were imprecise (Additional file 1:
Table e5).
Predictive values for treatment with inotropes/vasopressors
We found that 72 of the 158 patients diagnosed with
shock and with a medical chart available for review had
a code for inotropes/vasopressors. Treatment with ino-
tropes/vasopressors was confirmed in the medical chart
in 64 of the 72 cases, providing a PPV of 88.9% (95% CI:
79.3–95.1).
Predictive values for combined shock and
inotrope/vasopressor codes
The PPV for the shock diagnosis code in combination with
inotropes/vasopressors was 93.1% (95% CI: 84.5–97.7)
(Table 3). The PPV for shock subtypes combined with ino-
tropic/vasopressor therapy was 96.0% (95% CI: 89.6–99.9)
for cardiogenic shock, 69.2% (95% CI: 38.6–90.9) for hypo-
volemic shock, and 82.4% (95% CI: 65.5–93.2) for septic
shock (Table 3).
Discussion
We found a moderately high PPV for shock diagnoses
in the DNPR. For subtypes of shock, cardiogenic shock
diagnosis had the highest PPV, whereas more patients
diagnosed with hypovolemic and septic shock did not
fulfill the diagnostic criteria for these two types of
shock.
Procedure codes for treatment with inotropes/vaso-
pressors had also a high PPV. The PPVs for shock were
improved when the diagnosis code for shock overall
and cardiogenic or septic shock were combined with
the procedure code for inotropes/vasopressors. How-
ever, the PPV was unchanged for hypovolemic shock
when combined with procedure codes for inotropes/
vasopressors.
Existing studies
Our finding for the PPV for cardiogenic shock is some-
what higher than results from hospital discharge registries
from Canada [6,7]. Lawrence et al. found a PPV of 75.0%
(95% CI: 19.4–99.4) for cardiogenic shock among patients
with acute myocardial infarction in a hospital discharge
Figure 1 Flowchart of study population. Overview of patient selection from the DNPR, available medical charts, and confirmed diagnostic
criteria for subtypes of shock.
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limited size, with only four patients registered with ICD-
10 data for shock [6]. Another Canadian study of 66 pa-
tients diagnosed with an International Classification of
Diseases, 9th revision (ICD-9) code for cardiogenic shock
in Quebec’s hospital discharge registry reported a PPV of
78.8% (95% CI: 67.0–87.9) [7]. Similar to our finding for
septic shock, a study from the University of Michigan
Health Systems examined the PPV for ICD-9 codes forTable 2 Age, gender, and comorbidity among patients with a
Shock type
Covariates Shock overall 158 (100)a Cardiogenic shock 4
Demographics
Age, median, (IQR) 71 (61–80) 70 (59–76)
Male gender 77 (49) 25 (54)
CCIb score
Low 52 (33) 25 (54)
Moderate 57 (36) 14 (30)
High 49 (31) 7 (15)
aValues expressed as count (percentage) unless otherwise indicated.
bThree levels of comorbidity were defined based on Charlson Comorbidity Index sc
Abbreviations: CCI Charlson comorbidity index, IQR Interquartile range.severe sepsis, including septic shock, among 111 patients
and found a PPV of 70.7% (95% CI: 51.1–90.4) [8].
Strengths and limitations
Because we reviewed medical chart data from patients
with a registered ICD-10 diagnosis code of shock, we
could only estimate the PPV and not other measures of
validity including negative predictive value, sensitivity,
and specificity. Other studies found the sensitivity forn available medical chart
6 (100)a Hypovolemic shock 34 (100)a Septic shock 78 (100)a
69 (60–82) 73 (63–81)
14 (41) 38 (49)
10 (29) 17 (22)
10 (29) 33 (42)
14 (41) 28 (36)
ores of 0 (low), 1–2 (moderate), and ≥3 (high).
Table 3 Positive predictive values in the Danish National Patient Registry with shock diagnoses, inotropic/vasopressor
therapy among patients with shock, and shock from the combination of diagnoses and inotropic/vasopressor therapy
Shocka No shock Total numberb Positive predictive value, % (95% CI)
Diagnosis codec
Shock 136 22 158 86.1 (79.7–91.1)
Cardiogenic shock 43 3 46 93.5 (82.1–98.6)
Hypovolemic shock 24 10 34 70.6 (52.5–84.9)
Septic shock 54 24 78 69.2 (57.7–79.2)
Procedure codec
Inotropes/vasopressors 67 5 72 93.1 (84.5–97.7)
Diagnosis codec + inotropic/vasopressor codec
Cardiogenic shock 24 1 25 96.0 (79.6–99.9)
Hypovolemic shock 9 4 13 69.2 (38.6–90.9)
Septic shock 28 6 34 82.4 (65.5–93.2)
aShock defined as a confirmed overall shock or subtype of shock by medical chart review.
bAll missing medical charts are excluded.
cDNPR codes: shock overall (R570, R571, R572, A41.9A), cardiogenic shock (R570), hypovolemic shock (R571), septic shock (R572, A41.9A), and inotropes/vasopressors
(BFHC92, BFHC93 (excluding BFHC93E-BFHC93H), BFHC95.
Abbreviation: CI Confidence interval.
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and specificity to be 99% [6,7]. Because we aimed to val-
idate the PPV and not sensitivity of the shock diagnoses,
it was not necessary to include a control group.
The medical chart review was not blinded, which could
have influenced the data collection. However, strict clinical
criteria in congruity with internationally-approved diag-
nostic criteria [1,15,16] for each shock subtype were de-
fined before the beginning of the data collection; thus, the
potential of subjective influence from the data collector
was limited. Still, it is a potential limitation that only one
author reviewed the data from the medical charts.
Because clinical cases do not always fulfill all diagnostic
criteria, some cases are coded with the most suitable code
for the course of the disease. Register-based research relies
on correct coding procedures, and the PPVs for septic
shock and hypovolemic shock reveal some degree of cod-
ing inaccuracy. It should also be noted that the criteria for
defining shock subtypes may not be mutually exclusive,
which may have influenced the PPVs for shock.
Medical charts were not available for all patients in
our sample. No substantial differences in the available
comorbidity level were found between the two groups of
patients, which is why the assumption of no difference
between patients with missing charts and those with
charts was not disproved.
This study was conducted at Aarhus University Hospital,
and all medical charts were randomly selected from
the DNPR, including 15 different departments in the
hospital. Coding practices between hospital settings
might vary. However, the diagnostic criteria for shock sub-
types follow national guidelines, which likely make our
results representative to other hospitals in Denmark.No previous study has examined the PPV of shock
codes registered in the DNPR, despite the fact that the
DNPR may be an important tool for research and quality
monitoring of shock. We found fairly high PPVs for
shock overall, and for subtypes of shock, which makes
these ICD-10 codes usable in studies of risk and progno-
sis based on data from the DNPR. However, the poten-
tial impact of misclassification of shock should be
considered when conducting such studies.
Conclusions
We found a moderately high PPV for shock overall in
the DNPR using the medical chart as the reference
standard. PPV was highest for cardiogenic shock and
lower for hypovolemic and septic shock. A feasible ap-
proach to increase the PPV of shock overall and of sep-
tic shock is to combine the diagnosis with the procedure
codes for treatment with inotropes/vasopressors. In
summary, the DNPR is a valuable tool for epidemio-
logical research of shock and subtypes of shock, espe-
cially cardiogenic shock.
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